FDA Inspection
Marlinz Pharma, LLCMarlinz Pharma, LLC – FDA Inspection, May 4, 2022
Record Details
This FDA Inspection record concerns Marlinz Pharma, LLC, with an inspection on May 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Marlinz Pharma, LLC
- Inspection Date
- May 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 4b5ea71f-b7cf-4f34-b34b-5fea311505bb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1169023
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.198(b)(1)Complaint Record required information
- 21 CFR 211.198(a)Procedures to be written and followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Marlinz Pharma, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Marlinz Pharma, LLC
- FDA Inspection 1008957 - 2017-02-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.